Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens

OBJECTIVE: Monoclonal antibodies (MAbs) directed against the CD20 and CD52 antigens are used increasingly in patients with multiple sclerosis (MS). Several life-threatening opportunistic infections have been reported in postmarketing case series. The aim of this study was to investigate the incidenc...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Open Forum Infect Dis
المؤلفون الرئيسيون: Zappulo, Emanuela, Buonomo, Antonio Riccardo, Saccà, Francesco, Russo, Cinzia Valeria, Scotto, Riccardo, Scalia, Giulia, Nozzolillo, Agostino, Lanzillo, Roberta, Tosone, Grazia, Gentile, Ivan
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2019
الموضوعات:
Major Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6837838/
https://ncbi.nlm.nih.gov/pubmed/31723572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz445
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة